As per MRFR analysis, the US Blood Pressure Test Market Size was estimated at 378 (USD Million) in 2023. The US Blood Pressure Test Market Industry is expected to grow from 480 (USD Million) in 2024 to 1,170 (USD Million) by 2035. The US Blood Pressure Test Market CAGR (growth rate) is expected to be around 8.437% during the forecast period (2025 - 2035).
The US Blood Pressure Test Market is experiencing significant growth driven by an increasing prevalence of hypertension and cardiovascular diseases among the population. Approximately 45% of adults in the US have hypertension, which heightens the demand for regular monitoring and testing. This trend is further supported by rising health awareness and proactive health management among consumers, leading to greater adoption of personal health devices, including home blood pressure monitors. There are numerous opportunities to be explored within the market. Telehealth services are becoming more integrated, allowing patients to consult with healthcare providers remotely while using connected blood pressure monitoring devices.
This offers a convenient way for patients to engage in their care and helps manage their conditions effectively. Additionally, initiatives by government health organizations encourage routine blood pressure screenings, which can enhance market penetration by promoting awareness and accessibility. In recent times, the market has seen a notable shift toward innovative technology such as the development of digital blood pressure monitors that provide data analytics and connectivity options to mobile apps. This change aligns with the growing trend of digital health solutions, allowing users to track their blood pressure trends over time conveniently.
Furthermore, the trend of personalized medicine is influencing blood pressure testing, where devices are designed to cater to individual patient requirements. Overall, the ongoing technological advancements, combined with a supportive regulatory environment focused on reducing the burden of hypertension, underscore the vibrant growth potentials within the US Blood Pressure Test Market.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
The US Blood Pressure Test Market Industry is witnessing growth due to the increasing prevalence of hypertension. According to the Centers for Disease Control and Prevention (CDC), nearly half of adults in the United States, approximately 116 million individuals, have high blood pressure, contributing to the increased demand for blood pressure testing devices. The American Heart Association also notes that the prevalence of hypertension is on the rise, citing a 6% increase in diagnosed cases over the last decade alone.
This surge in hypertension cases is creating a pressing need for regular blood pressure monitoring and testing, making it a key driver in the US Blood Pressure Test Market. Furthermore, initiatives such as the Million Hearts program, launched by the CDC and its partners, aim to prevent 1 million heart attacks and strokes over a five-year period, emphasizing the importance of early detection and management of hypertension. This focus on preventive health measures is likely to impact the market positively as more individuals seek blood pressure testing for better health management.
Advancements in technology are another critical driver of the US Blood Pressure Test Market Industry. Recent innovations include the development of wireless and wearable blood pressure monitoring devices, which allow for more convenient and accurate measurements. The integration of mobile health applications, such as those developed by organizations like Omron and Philips, has made it easier for individuals to track their blood pressure readings and share them with healthcare professionals.
According to the Food and Drug Administration (FDA), the approval of numerous innovative blood pressure devices has increased accessibility and patient engagement in health management, thereby contributing to market growth.
Government initiatives aimed at hypertension management play a significant role in boosting the US Blood Pressure Test Market Industry. The US Department of Health and Human Services has implemented various programs promoting awareness and prevention of high blood pressure. Educational campaigns and free screening events have resulted in increased public awareness and understanding of hypertension. For instance, the National Heart, Lung, and Blood Institute's efforts, including the 'Heart Month' campaigns, have led to a reported increase in the number of individuals getting regular blood pressure checks.
This increase has significant implications for the growth of the blood pressure testing market in the US.
The US Blood Pressure Test Market is witnessing significant growth driven by the increasing prevalence of hypertension and related cardiovascular diseases among the population. The Product segment is a crucial area within this market, comprising various key components that facilitate blood pressure monitoring. Sphygmomanometers play a vital role in traditional blood pressure measurement; their reliability and accuracy make them a preferred choice among healthcare professionals. This instrument is essential for clinical assessments and is frequently used in hospitals, clinics, and home care settings.
Blood pressure transducers, which convert pressure into an electrical signal, are becoming increasingly important in modern diagnostic settings due to their ability to provide continuous and accurate readings, thus enhancing patient monitoring. Instrument accessories, which support and enhance the functionality of blood pressure measurement devices, are often overlooked yet play a significant role in providing comprehensive care. These accessories include cuffs, hoses, and adapters that ensure proper device utilization. The growing focus on preventive healthcare and remote patient monitoring is anticipated to drive innovation in these Product segments, facilitating enhanced accuracy and efficiency in blood pressure management.
As the US healthcare system adapts to changing patient needs, the relevance of these Products in offering reliable hypertension management solutions is continually underscored. Furthermore, the aging population in the United States is a critical factor contributing to the expansion of the blood pressure testing market, as older adults are more prone to blood pressure-related health issues, thereby increasing the demand for these essential diagnostic tools. Overall, this Product segment within the US Blood Pressure Test Market represents a significant opportunity for advancement and improvement in hypertension detection and management, ultimately contributing to better health outcomes for the population.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
The US Blood Pressure Test Market, particularly within the Indication segment, encompasses critical health conditions such as hypertension and coronary heart disease, both of which significantly impact public health. Hypertension, often termed the silent killer, affects millions of Americans and is a key driver for regular blood pressure monitoring. The integration of advanced testing technologies has improved early detection and management, essential for reducing complications associated with this condition. Coronary heart disease, a leading cause of mortality in the U.S., also underscores the necessity of routine blood pressure tests, as high blood pressure is a major risk factor.
The emphasis on preventative care in the healthcare system promotes increased demand for blood pressure tests, aligning with national health objectives aimed at reducing cardiovascular morbidity and mortality. Both indications represent vital areas for market growth, fueled by rising awareness, better diagnostics technology, and a growing aging population, further reinforcing the critical role of blood pressure testing in the healthcare continuum. The continuous focus on managing these conditions indicates a robust opportunity for advancements in blood pressure test technologies and methodology.
The US Blood Pressure Test Market is significantly influenced by its End User category, which includes various healthcare settings such as hospitals, clinics, and diagnostic centers. Hospitals represent a critical portion of this market, as they are often the first point of contact for patients requiring blood pressure assessments, facilitated by emergency care and inpatient monitoring. Clinics serve an essential role in providing routine check-ups and chronic disease management, making them vital for early detection and proactive care, thus supporting the overall healthcare system in managing hypertension effectively. Diagnostic centers, specializing in providing specific tests, contribute to developing precise blood pressure monitoring solutions; they allow for specialized testing environments that enhance accuracy and reliability in results.
The increasing awareness of cardiovascular diseases coupled with a rise in health-conscious populations drives demand across these segments. Additionally, advancements in technology and telehealth services present opportunities to improve patient care, ensuring more accessible, efficient blood pressure monitoring. As the market continues to evolve, ensuring quality results in these settings remains a primary focus, supporting the growth and innovation of the US Blood Pressure Test Market.
The US Blood Pressure Test Market is a dynamic sector reflecting the increasing awareness around cardiovascular health and the need for early detection of hypertension. With the growing prevalence of lifestyle-related diseases, the demand for blood pressure monitoring devices has surged. The market is characterized by a mix of technologically advanced products and traditional devices, catering to both home users and healthcare providers. Competitive insights within this market reveal a landscape where innovation and customer engagement are key differentiators, with many companies investing in smart technology, remote monitoring capabilities, and user-friendly designs to capture a larger share of the growing population concerned about blood pressure management.
The competitive dynamics are further influenced by regulatory approvals, reimbursement policies, and consumer preferences towards more advanced and convenient health monitoring solutions. Omron Healthcare has established a robust presence in the US Blood Pressure Test Market, distinguished by its wide range of clinically validated devices. The company is known for its commitment to innovation, having developed advanced blood pressure monitors that feature Bluetooth connectivity to sync with mobile applications for better health tracking. As a pioneer in home healthcare technology, Omron Healthcare emphasizes accuracy and ease of use, appealing to both consumers and healthcare professionals. Their strength lies in their established brand reputation, significant market penetration, and a vast distribution network that encompasses online and retail channels. Furthermore, the company often engages in educational initiatives to promote awareness about hypertension, enhancing customer loyalty and trust in their products.
HillRom Holdings, operating within the US Blood Pressure Test Market, focuses on delivering high-quality health solutions that cater to the needs of healthcare providers. The company is recognized for its innovative blood pressure monitoring systems integrated with digital health solutions aimed at improving patient care and clinical efficiency. HillRom's strengths lie in their comprehensive portfolio of medical devices, including advanced patient monitoring systems and software that allow for real-time data collection. Their commitment to innovation is strengthened through strategic partnerships and collaborations, enhancing their technology capabilities. Mergers and acquisitions have also played a significant role in bolstering HillRom’s market position, enabling them to expand their product offerings and enhance their service capabilities tailored to the US market. HillRom’s focus on addressing critical care challenges and delivering integrated solutions uniquely positions them to succeed in the competitive landscape of the blood pressure test market.
The US Blood Pressure Test Market has seen significant advancements recently, particularly in advancing diagnostic technologies and patient monitoring solutions. Notable developments include Omron Healthcare’s introduction of new innovative devices aimed at promoting home-based blood pressure monitoring, which has gained traction due to increasing consumer health awareness. HillRom Holdings has expanded its product portfolio, focusing on the integration of cloud technologies for remote patient monitoring solutions. In terms of mergers and acquisitions, no recent deals have been reported involving major players in the market such as Roche Diagnostics, Takeda Pharmaceutical, or Medtronic, within the last three months.
The market's growth has been further fueled by an increased emphasis on telehealth services, establishing a broad market valuation opportunity for companies like Abbott Laboratories and Baxter International. Moreover, Welch Allyn’s partnerships with healthcare providers aim to enhance the accessibility of testing devices, reflecting a broader trend towards improved healthcare delivery models. Over the past couple of years, particularly from January 2021 to October 2023, the market has undergone transformation influenced by regulatory support for electronic health records and the push for integrated health solutions across the United States.
| Report Attribute/Metric Source: | Details |
| MARKET SIZE 2018 | 378.0(USD Million) |
| MARKET SIZE 2024 | 480.0(USD Million) |
| MARKET SIZE 2035 | 1170.0(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 8.437% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| HISTORICAL DATA | 2019 - 2024 |
| MARKET FORECAST UNITS | USD Million |
| KEY COMPANIES PROFILED | Omron Healthcare, HillRom Holdings, Roche Diagnostics, Takeda Pharmaceutical, Medtronic, Abbott Laboratories, Baxter International, Welch Allyn, Microlife Corporation, A and D Medical, Cardinal Health, GE Healthcare, Philips Healthcare |
| SEGMENTS COVERED | Product, Indication, End User |
| KEY MARKET OPPORTUNITIES | Telehealth integration for remote monitoring, Increasing home testing demand, Advanced wearable technology adoption, Aging population driving needs, Preventive health management initiatives |
| KEY MARKET DYNAMICS | Increasing hypertension prevalence, Technological advancements in devices, Growing health consciousness, Rising geriatric population, Favorable reimbursement policies |
| COUNTRIES COVERED | US |
Frequently Asked Questions (FAQ) :
The US Blood Pressure Test Market is expected to be valued at 480.0 million USD in 2024.
By 2035, the US Blood Pressure Test Market is projected to reach a value of 1170.0 million USD.
The expected CAGR for the US Blood Pressure Test Market from 2025 to 2035 is 8.437%.
The main product segments in the US Blood Pressure Test Market include sphygmomanometers, blood pressure transducers, and instrument accessories.
The sphygmomanometers segment is expected to be valued at 400.0 million USD by 2035.
The blood pressure transducers segment is expected to be valued at 150.0 million USD in 2024.
The instrument accessories segment is projected to grow to 420.0 million USD by 2035.
Some major players in the US Blood Pressure Test Market include Omron Healthcare, HillRom Holdings, and Roche Diagnostics, among others.
Key growth drivers for the US Blood Pressure Test Market include an increasing prevalence of hypertension and a growing aging population.
Challenges facing the US Blood Pressure Test Market include regulatory hurdles and competition among various manufacturers.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Analyst Explore the profile of garvit vyas, one of our esteemed authors at market research future, and access their expert research contributions in the field of market research and industry analysis
Get in Touch
© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
